Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
HyperMu Transposon from EPICENTRE Biotechnologies
Rhesus Macaque IFN-alpha from R&D Systems
Sheep Anti-chk 1 kinase Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Biology Products:(Date:11/25/2009)...EIJING,Nov.25/PRNewswire-Asia/--SinovacBiotechLtd....uncedtodaythatitexecuted,ajointventure(JV)agreemen...td.(SinovacDalian).TheJVwillresearch,develop,produ...ntributeitsexpertise,andexperienceindevelopingandc...llbringitslanduserights,manufacturingfacilitiesand...
(Date:11/24/2009)...elease is available in German . , Whether i...ds: RFID tags (Radio Frequency Identification) are.... They make it possible to label objects or goods .... The appropriate scanner can read and process the...affixed to goods under production conditions of up...
(Date:11/24/2009)... The New York investment bank KTA ...EU) has agreed an AU$6.7 mil convertible note priv...The private placement was arranged by KTA Capital ... , New York (PRWEB) Novem...t bank KTA Capital, LLC ("KTA Capital") ...
(Date:11/24/2009)...EYKJAVIK,Iceland,November24/PRNewswire-FirstCall/-...thatithasreceivednoticefrom,theNasdaqStockMarketth...asofNovember30,2009andaForm25-NSEwillbefiledwithth...eCODE,scommonstock,fromlistingonNasdaq,unlesstheco...sPanel.Thecompanyhasfiledsuchanappeal,which,willst...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3